Overview of APIs and their Parameters

Drugs API:

The Drugs API delivers information from the AdisInsight drug profile. These profiles tell the ongoing story of a drug's progress through discovery, preclinical testing, clinical trials, and regulatory approval. They contain a rich collection of information including development status summary table (indication, patient segment, phase of development, country, route/formulation, developer), involved organization table (organization, involvement type, countries), commercial summary (brand names, market status, financial forecast), development overview, properties and chemical synopsis, biomarkers, scientific summary, future events, development history, and references.

Pharma companies use the Drugs API to help researchers find new drug development opportunities, repurpose existing/failed drugs, and determine druggable therapeutic targets. It can help business development and licensing to identify and quickly evaluate opportunities. It can be used to identify future competitors, evaluate their strengths/weaknesses, and track their progress for portfolio strategy and product planning.

Finance organizations use the Drugs API as an alternative data source to determine trading strategies, assess potential investment opportunities based on company asset performance, and easily find the data needed to support business and investment decisions based on the most compelling scientific and commercial information.

Technology partners use the Drug API for training and input into their AI and Machine Learning models to provide outcomes learn from research and real-world clinical evidence produced and vetted by human experts.

Output is available in JSON (default) and XML format. API calls can be made using the following input parameters.

• Drug IDs: A unique identifier that represents a drug profile which contains data regarding end-to-end development of a compound with an organisation.
• Organisation: An organisation or organisations that are involved in the development of a specific molecule.
• Phase: The development phase for the indication searched, or the most advanced development phase across all indications for a drug profile.
• Location: The country related to a particular phase for drug development of a drug.
• Indication: A sign, symptom, or medical condition that a drug development program is targeting.
• Mechanism of Action: A process by which a drug functions to produce a pharmacological effect.
• Drug Class: Groupings of drugs that have similar chemical, biological and/or therapeutic actions.

Trials API:

The Trials API delivers information from the AdisInsight trial profile. These profiles report the progress of a clinical trial from planning to completion and summarize the key results being reported for efficacy and safety. They contain detailed information about the purpose, endpoints, and outcomes for the study. Information about patient demographics, inclusion, and exclusion criteria for subjects enrolled in the study. Information about design, location, sponsors, and dates for the study. Information about treatment arms and focus for the study. Summaries of efficacy and safety. Lists of trial centres and investigators.

BioPharma companies use the Trials API to map the clinical trial landscape, plan better clinical trials, and identify treatment gaps. Technology partners use the Trials API for training and input into their AI and Machine Learning models to provide outcomes learn from research and real-world clinical evidence produced and vetted by human experts.

Output is available in JSON (default) and XML format. API calls can be made using the following input parameters.

• Indication: A sign, symptom, or medical condition that a drug development is targeting.
• Phase: The development phase for the indication searched, or the most advanced development phase across all indications.
• Status: The progression of the clinical trial from planning to recruitment to completion.
• Organisation: An organisation or organisations that are affiliated with the clinical trial.
• Primary Drug Name: The name of the drug or drugs that are being evaluated in the trial.
• Trial Focus: Why the trial is being conducted, for example registrational, expanded access, pharmacokinetics, etc.
• Update Date: The date the trial profile was last updated.

Timelines API:

AdisInsight Timelines provides end users with the data needed to conduct trend analysis over time. Drug researchers can uncover historical shifts in treatment mechanism, target, and/or technology. BioPharma strategists can assess markets and conduct situational analysis. Life science investors can find relationships between real world activities and movement in the market.

AdisInsight Timelines is an archive of key fields from AdisInsight drug profiles recorded on the first day of each month since 2004. These fields include unique ID number, drug name, drug name synonyms, mechanism of action, originator organization name, licensee organization name, and paired indication plus phase of development plus country.

Output is available in JSON format. API calls can be made using the following input parameter.

• Date: The month and the year for which you want to retrieve records.